**Strong trader consensus at 94.5% for "No"** stems from the absence of any novel pathogen exhibiting sustained human-to-human transmission on a global scale in 2026. Official WHO and CDC surveillance data show only localized outbreaks, including the ongoing Bundibugyo virus Ebola event in the DRC—now exceeding 5,000 cases and declared a PHEIC—with high regional risk but low international spread due to limited transmissibility and effective containment measures. Avian influenza strains like H5N1 demonstrate zoonotic spillover and mammalian adaptation but lack efficient airborne person-to-person chains, keeping overall pandemic risk low. Historical patterns confirm such events require rare alignments of high R0, immune evasion, and geographic reach not observed currently. Realistic challenges include an unexpected mutation enabling sustained transmission or undetected surveillance gaps, though these remain low-probability before year-end.